Literature DB >> 10722627

Effects of Shiga toxin 2 on lethality, fetuses, delivery, and puerperal behavior in pregnant mice.

K Yoshimura1, J Fujii, A Tanimoto, T Yutsudo, M Kashimura, S Yoshida.   

Abstract

Shiga toxin 2 (Stx2) is produced by enterohemorrhagic Escherichia coli (EHEC) and is known as the major virulence factor of EHEC. The aim of this study was to evaluate the effects of Stx2 on (i) maternal lethality, (ii) fetuses, (iii) delivery period, and (iv) maternal behavior after delivery. Timed pregnant ICR mice were injected intravenously with Stx2 on day 5 of pregnancy (early stage) or on day 15 (late stage). In early-stage experiments, the number of normal fetuses of mice injected with Stx2 was significantly lower than that of control mice. In late-stage experiments, mothers injected with Stx2 delivered normal numbers of neonates, but could not take care of them. The lethal doses of Stx2 were not different for pregnant and nonpregnant female mice at either stage. We conclude that Stx2 is toxic to the fetus in early pregnancy and affects maternal puerperal behavior in late pregnancy.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10722627      PMCID: PMC97411          DOI: 10.1128/IAI.68.4.2254-2258.2000

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  22 in total

1.  [Detection of bactericidal antibody in the breast milk of a mother infected with enterohemorrhagic Escherichia coli O157:H7].

Authors:  E Adachi; H Tanaka; N Toyoda; T Takeda
Journal:  Kansenshogaku Zasshi       Date:  1999-05

2.  Properties of strains of Escherichia coli belonging to serogroup O157 with special reference to production of Vero cytotoxins VT1 and VT2.

Authors:  S M Scotland; G A Willshaw; H R Smith; B Rowe
Journal:  Epidemiol Infect       Date:  1987-12       Impact factor: 2.451

3.  A case-control study of chorioamnionic infection and histologic chorioamnionitis in prematurity.

Authors:  S L Hillier; J Martius; M Krohn; N Kiviat; K K Holmes; D A Eschenbach
Journal:  N Engl J Med       Date:  1988-10-13       Impact factor: 91.245

4.  Infections with Escherichia coli O157:H7 in Washington State. The first year of statewide disease surveillance.

Authors:  S M Ostroff; J M Kobayashi; J H Lewis
Journal:  JAMA       Date:  1989-07-21       Impact factor: 56.272

5.  Colonic biopsy in verotoxin-induced hemorrhagic colitis and thrombotic thrombocytopenic purpura (TTP).

Authors:  D M Morrison; D L Tyrrell; L D Jewell
Journal:  Am J Clin Pathol       Date:  1986-07       Impact factor: 2.493

6.  Sporadic cases of haemolytic-uraemic syndrome associated with faecal cytotoxin and cytotoxin-producing Escherichia coli in stools.

Authors:  M A Karmali; B T Steele; M Petric; C Lim
Journal:  Lancet       Date:  1983-03-19       Impact factor: 79.321

7.  Glycolipid binding of purified and recombinant Escherichia coli produced verotoxin in vitro.

Authors:  C A Lingwood; H Law; S Richardson; M Petric; J L Brunton; S De Grandis; M Karmali
Journal:  J Biol Chem       Date:  1987-06-25       Impact factor: 5.157

8.  Purification and some properties of a Vero toxin from Escherichia coli O157:H7 that is immunologically unrelated to Shiga toxin.

Authors:  T Yutsudo; N Nakabayashi; T Hirayama; Y Takeda
Journal:  Microb Pathog       Date:  1987-07       Impact factor: 3.738

Review 9.  Infection by verocytotoxin-producing Escherichia coli.

Authors:  M A Karmali
Journal:  Clin Microbiol Rev       Date:  1989-01       Impact factor: 26.132

10.  The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli.

Authors:  M A Karmali; M Petric; C Lim; P C Fleming; G S Arbus; H Lior
Journal:  J Infect Dis       Date:  1985-05       Impact factor: 5.226

View more
  4 in total

1.  The common ovine Shiga toxin 2-containing Escherichia coli serotypes and human isolates of the same serotypes possess a Stx2d toxin type.

Authors:  V Ramachandran; M A Hornitzky; K A Bettelheim; M J Walker; S P Djordjevic
Journal:  J Clin Microbiol       Date:  2001-05       Impact factor: 5.948

2.  Fusion expression and immunogenicity of EHEC EspA-Stx2Al protein: implications for the vaccine development.

Authors:  Yan Cheng; Youjun Feng; Ping Luo; Jiang Gu; Shu Yu; Wei-jun Zhang; Yan-qing Liu; Qing-Xu Wang; Quan-ming Zou; Xu-hu Mao
Journal:  J Microbiol       Date:  2009-09-09       Impact factor: 3.422

3.  Effects of Shiga toxin type 2 on maternal and fetal status in rats in the early stage of pregnancy.

Authors:  Flavia Sacerdoti; María M Amaral; Elsa Zotta; Ana M Franchi; Cristina Ibarra
Journal:  Biomed Res Int       Date:  2014-05-05       Impact factor: 3.411

Review 4.  Shiga Toxin-Producing Escherichia coli Infections during Pregnancy.

Authors:  Flavia Sacerdoti; María Luján Scalise; Juliana Burdet; María Marta Amaral; Ana María Franchi; Cristina Ibarra
Journal:  Microorganisms       Date:  2018-10-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.